Stock Groups

How Johnson & Johnson became the sprawling healthcare giant it is today -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: A primary support package made by Johnson & Johnson on the market on a retailer shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking

By Carl O’Donnell

(Reuters) – Johnson & Johnson (NYSE:) plans to spin off its shopper well being division that sells Listerine and Child Powder to give attention to prescribed drugs and medical units within the greatest shake-up within the U.S. firm’s 135-year historical past.

Right here is how J&J bought to the place it’s right now.

1886

Robert Wooden Johnson companions with brothers James Wooden Johnson and Edward Mead Johnson to discovered Johnson & Johnson in 1886. It initially targeted on ready-to-use sterile surgical dressings.

1894

J&J begins producing Johnson’s Child Powder.

1918

In response to a world flu pandemic, J&J begins promoting a masks designed to restrict the unfold of the airborne viral sickness.

1920

J&J invents Band-Assist and begins advertising and marketing it in 1921.

1944

J&J completes its preliminary public providing and turns into a publicly traded firm. It had annual gross sales of round $95 million on the time, in comparison with greater than $80 billion in 2020.

1959

J&J acquires Tylenol maker McNeil Laboratories.

1961

J&J acquires Janssen Prescription drugs, which now makes ADHD drug Concerta and J&J’s COVID-19 vaccine.

1997

The primary lawsuit alleging that J&J’s Child Powder comprises cancer-causing asbestos is filed towards J&J. Since then, J&J has confronted 1000’s of lawsuits and billions of liabilities and has ceased distributing Child Powder in the USA and Canada.

1999

J&J acquires Centocor Biotech Inc, maker of Remicade for Crohn’s illness, and renames it Janssen Biotech.

2012

Johnson and Johnson acquires orthopedic machine maker Synthes for practically $20 billion to increase its medical product choices.

2017

J&J acquires Actelion for $30 billion, including coronary heart illness medicines resembling Tracleer to its portfolio.

2020

J&J begins growing a COVID-19 vaccine. It acquired authorization to start administering its COVID-19 shot the next 12 months.

Sources:

https://www.jnj.com

https://www.asbestos.com/firms/johnson-johnson

https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer

Disclaimer: Fusion Media want to remind you that the info contained on this web site just isn’t essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs should not offered by exchanges however reasonably by market makers, and so costs might not be correct and should differ from the precise market value, that means costs are indicative and never acceptable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any accountability for any buying and selling losses you would possibly incur because of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury because of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding kinds doable.



[ad_2]